Collaborative work unravels hidden molecular secrets of age-related diseases

Science Instruments in laboratory room. Science Research Concept.

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, and the University of Copenhagen announced today the release of the first batch of results from the collaborative work directed to perform multi-omics-based analyses in the context of age-related diseases using an AI-driven target and drug discovery pipeline.

What the Respect for Marriage Act does and doesn’t do

Previous article

Studies into video telemedicine diagnostic accuracy and patient satisfaction find positive trends

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News